baber/WOPTO huggingface dataset:
Patent AU-2020200469-A1 (AU)
Title: Surgical stapler with small diameter endoscopic portion
Inventor: WHITFIELD KENNETH
IPC: A61B17/076
Filed: 2020-01-23
Abstract: SURGICAL STAPLER WITH SMALL DIAMETER ENDOSCOPIC 
PORTION 
ABSTRACT 
A surgical stapler (10) including a shipping lock (400) configured to obstruct movement of a 
drive member (336) is provided. The surgical stapler (10) includes an elongate body (302), a 
tool assembly (306) pivotally secured to the elongate body (302), a drive member (336) movable 
within the tool assembly (306) between retracted and advanced positions, and a shipping lock 
(400) releasably secured to the elongate body (302). The shipping lock (400) includes a 
projection (412). When the shipping lock (400) is secured to the elongate body (302), the 
projection (412) obstructs movement of the drive member (336) to its advanced position.
27/27 
CDN 
c.  
C=>, 
CLC> 
(0>
Patent AU-2020203632-A1 (AU)
Title: Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
Inventor: NEBOLSIN VLADIMIR EVGENIEVICH
IPC: A61K31/34
Filed: 2020-06-02
Abstract: C:\Interwo n\NRPortbl\DCCSXD\17778026_l.docx-27/09/2018 The present invention relates to novel biologically active glutarimide derivatives of general formula (I) or pharmaceutically acceptable salts thereof, the use thereof as agents for treating upper respiratory tract diseases, pharmaceutical compositions containing glutarimide derivatives of general formula (I), and methods for producing glutarimide derivatives of general formula (I) by heating a dicarboxylic acid monoamide of general formula (II) with a dehydrating agent.
Patent AU-2020207779-A1 (AU)
Title: Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
Inventor: MRSNY RANDALL J
IPC: A61P1/00
Filed: 2020-07-20
Abstract: The present disclosure relates to pharmaceutical compositions comprising a non-naturally 
occurring fusion molecule and one or more pharmaceutically acceptable carriers, formulated 
for oral delivery to a subject, and designed to provide for improved, effective therapies for 
treatment of, e.g., inflammatory diseases, autoimmune diseases, cancer, metabolic disorders, 
and growth deficiency disorders.
Patent AU-2020212757-A1 (AU)
Title: Communication method and communications apparatus
Inventor: ZHANG DI
IPC: H04W28/02
Filed: 2020-01-22
Abstract: Provided are a communication method and a communication apparatus. The communication method comprises: sending first information on a first resource, wherein the first information is used for indicating a link failure; receiving second information, wherein the second information is used for indicating a second resource; and according to the second information, sending third information on the second resource, wherein the third information is used for indicating a first reference signal and/or a first cell, the channel quality of the first reference signal being greater than or equal to a preset threshold, and a link failure occurring in the first cell. By means of the communication method, the time delay of link recovery can be reduced.
Patent AU-2020221359-A1 (AU)
Title: Charge-bearing cyclodextrin polymeric materials and methods of making and using same
Inventor: BARIN Gokhan
IPC: C02F1/28
Filed: 2020-02-13
Abstract: The present disclosure relates to charge-bearing polymeric materials and methods of their use for purifying fluid samples from micropollutants, such as anionic micropollutants.
Patent AU-2020239621-A1 (AU)
Title: Pharmaceutical formulations of Her2 antibody-drug conjugate
Inventor: XU QIAOYU
IPC: A61P35/00
Filed: 2020-03-25
Abstract: The invention relates to a pharmaceutical formulation comprising a mixture of a 
non-reducing sugar, a recombinant humanized anti-Her2 monoclonal antibody-MMAE conjugate, 
and a surfactant. The pharmaceutical formulation has characteristics of reduced particulate matter, 
reduced aggregates, improved stability of the conjugate, improved appearance of the lyophilized 
5 powders and the like.
Patent AU-2020267647-A1 (AU)
Title: Apparatus for locating a mobile railway asset
Inventor: BONNES MATTHEW
IPC: G01S19/03
Filed: 2020-05-07
Abstract: In one aspect of the present disclosure, an apparatus for locating a mobile railway asset is provided that includes a power source, GNSS circuitry configured to utilize electrical power from the power source to receive GNSS data, and a controller operatively coupled to the power source and the GNSS circuitry. The controller has a power saving mode wherein the controller inhibits the GNSS circuitry from receiving GNSS data and a standard accuracy mode wherein the controller permits the GNSS circuitry to receive GNSS data for a first time period. The controller has a higher accuracy mode wherein the controller permits the GNSS circuitry to receive GNSS data for a second time period longer than the first time period, and subsequently across multiple instances, in order to collect more GNSS data that can be qualified, filtered, sorted, and averaged to produce a more accurate result.
Patent AU-2020296197-A1 (AU)
Title: Chimeric protein expressing T-cells
Inventor: SCHREIBER TAYLOR
IPC: C12N7/00
Filed: 2020-06-22
Abstract: The present invention relates to, inter alia, compositions and methods, including engineered T cells that express chimeric antigen receptors and heterologous chimeric proteins that find use in the treatment of cancer.
Patent AU-2020310945-A1 (AU)
Title: Salinity and/or sodicity tolerant plants
Inventor: GENC YUSUF
IPC: A01H6/46
Filed: 2020-07-03
Abstract: The present invention is directed to salinity and/or sodicity tolerant plants. Specifically, methods for producing plants having salinity and/or sodicity tolerance are provided, together with plants produced therefrom. The present invention is also directed to genetic markers (including single nucleotide polymorphisms and genes) associated with salinity and/or sodicity tolerance in plants, as well as methods for identifying plants using said markers. Methods for increasing the salinity and/or sodicity tolerance of a plant are also encompassed herein. Furthermore, the present invention provides wheat plants having salinity and/or sodicity tolerance, as well as salinity and/or sodicity tolerant wheat germplasm and uses thereof.
Patent AU-2020361625-A1 (AU)
Title: Oncolytic virus comprising immunomodulatory transgenes and uses thereof
Inventor: MCFADDEN DOUGLAS GRANT
IPC: A61K9/08
Filed: 2020-10-09
Abstract: The disclosure provides Myxoma virus that expresses one or more immunomodulatory transgenes and its use in inhibiting and/or treating a hematological cancer in a subject. The disclosure also provides a leukocyte having a Myxoma virus that expresses one or more immunomodulatory transgenes and the use of the leukocyte for inhibiting and/or treating a hematological cancer in a subject.
Patent AU-2020377394-A1 (AU)
Title: Hierarchical deep neural network forecasting of cashflows with linear algebraic constraints
Inventor: Dasgupta Sambarta
IPC: G06N3/04
Filed: 2020-07-08
Abstract: INTU1811354WO 
ABSTRACT 
Systems and methods for forecasting cashflows across one or more accounts of a 
user disclosed. One example method may include retrieving a data set for each of a 
plurality of accounts from a database, constructing a graph including a plurality of 
nodes linked together by a multitude of edges, wherein each node identifies a time 
series value corresponding to one of the accounts, and each edge indicates a time series 
value of a corresponding set of transactions occurring between a corresponding pair of 
accounts, determining a plurality of constraints, determining a specified loss function 
based on the plurality of constraints, back-propagating a derivative of the specified loss 
function into a deep neural network (DNN) to determine a set of neural network 
parameters, forecasting, using the DNN, a time sequence for one or more of the nodes 
and one or more of the edges, and providing the forecasted time sequences to the user.  
30
Patent WO-2021195716-A1 (WO)
Inventor: CRYLE MAX
IPC: A61K38/00
Filed: 2021-04-01
Abstract: The present invention relates to conjugates comprising a glycopeptide antibiotic agent and a chemotactic formylated peptide and their use in the treatment or prevention of bacterial infections. The invention also relates to use of the conjugates in the prevention or treatment of bacterial infections.
Patent AU-2021202893-A1 (AU)
Title: Ameliorating the spread of infectious disease
Inventor: HADDAD LOBNA
IPC: A47K5/12
Filed: 2021-05-07
Abstract: Apparatus for ameliorating the spread of infectious disease, the apparatus including a cover 
configured to be applied to a high contact surface, the cover including an antimicrobial 
additive and a dispenser configured to apply an antimicrobial agent to a hand of the user to 
allow the user to apply the antimicrobial agent before and/or after touching the cover.
11/17 
710 
712 
x 713 
622 
700 
620 82 835 
621 
831 
830 
Fig.8A
Patent AU-2021203773-A1 (AU)
Title: Arrangements and methods for avoiding spreading of infectious agents and improving electric safety and suction performance of a medical aspirator
Inventor: TJOLSEN OYVIND
IPC: A61M1/00
Filed: 2021-06-08
Abstract: Vacuum pump for a medical aspirator, the pump comprising a tubular 
member; a piston slidably arranged within the tubular member; a piston 
rod connected to the piston; and a coupling mechanism for detachably 
5 and functionally connecting the piston rod to a motor for driving the 
pump, wherein the piston rod is configured to reciprocate linearly during 
operation of the pump.  
(Fig. 2a)
2/7 
64 10 
C 10 
64 48 
66 16 
Fig. 2b
Patent AU-2021204703-A1 (AU)
Title: Flow regulating inhaler device
Inventor: DAVIDSON PERRY
IPC: A61M11/04
Filed: 2021-07-05
Abstract: An inhaler device for delivery of at least one active substance to an inhaling user 
comprises a first conduit for conducting airflow to an opening from which the user 
inhales; a valve positioned and configured to affect flow of ambient air into the first 
conduit; a controller configured to control release of the at least one active substance to 
be carried by the airflow to the inhaling user. The controller is further configured to 
control the valve to generate a pattern of airflow and active substance delivery 
modulations. The pattern includes and there is also a method disclosed which includes: 
(a) delivering the active substance via the airflow followed by substantially stopping 
active substance delivery and reducing a total rate of airflow to the user for an 
intermediate period, and then 
(b) increasing the airflow without resuming active substance delivery to a rate or volume 
sufficient to be sensed by the inhaling user.
Patent AU-2021231850-A1 (AU)
Title: Systems and methods of speaker-independent embedding for identification and verification from audio
Inventor: PHATAK KEDAR
IPC: G10L17/00
Filed: 2021-03-04
Abstract: Embodiments described herein provide for audio processing operations that evaluate characteristics of audio signals that are independent of the speaker's voice. A neural network architecture trains and applies discriminatory neural networks tasked with modelling and classifying speaker-independent characteristics. The task-specific models generate or extract feature vectors from input audio data based on the trained embedding extraction models. The embeddings from the task-specific models are concatenated to form a deep-phoneprint vector for the input audio signal. The DP vector is a low dimensional representation of the each of the speaker-independent characteristics of the audio signal and applied in various downstream operations.
Patent AU-2021232697-A1 (AU)
Title: A luminescent photonic structure, a method of fabricating a luminescent photonic structure, and a method of sensing a chemical substance
Inventor: QIN LI
IPC: B82Y40/00
Filed: 2021-09-14
Abstract: Disclosed herein is a luminescent photonic structure. The luminescent photonic structure comprises 
a luminescent material that when excited by an excitation light having a wavelength within an 
excitation wavelength spectrum of the luminescent material emits luminescent light having a 
luminescence wavelength spectrum. The luminescent photonic structure comprises a photonic 
crystal disposed between two other photonic crystals. The photonic crystal has a photonic lattice 
period within one of the luminescence wavelength spectrum and the excitation wavelength 
spectrum. The two other photonic crystals each have a photonic lattice period within the other of 
the luminescence wavelength spectrum and the excitation wavelength spectrum for reflecting one 
of excitation light and luminescent light propagating within the photonic crystal. Also disclosed 
herein is a method for fabricating a luminescent photonic structure, and a method for sensing a 
chemical substance.
Patent AU-2021250976-A1 (AU)
Title: Nitric oxide inhalation therapy for infants with bronchiolitis
Inventor: AV-GAY YOSSEF
IPC: A61P9/00
Filed: 2021-10-15
Abstract: In some embodiments, the present invention provides a method for treating bronchiolitis in an 
infant in need thereof, wherein the wherein the method comprises repeatedly administering to 
the infant a gas mixture comprising nitric oxide at a concentration from about 144 to about 176 
ppm for a first period of time, followed by a gas mixture containing no nitric oxide for a second 
period of time, 
wherein the administration is repeated for a time sufficient to: 
a) reduce the length of time of hospitalization required to achieve 
oxygen saturation greater than or equal to 92% in room air, compared 
an infant that is not subjected to the repeated administration of nitric 
oxide; 
b) reduce the length of time of hospitalization required to achieve a 
clinical score of less than or equal to 5, compared an infant that is not 
subjected to the repeated administration of nitric oxide; 
c) reduce the length of time of hospitalization required to be discharged, 
compared an infant that is not subjected to the repeated administration 
of nitric oxide; or 
d) any combination thereof.
Patent AU-2021258088-A1 (AU)
Title: Detection of brain injury
Inventor: PATEL SARJUBHAI A
IPC: A61M1/00
Filed: 2021-10-29
Abstract: OF THE INVENTION 
The present invention provides minimally invasive methods of detecting, diagnosing, 
and assessing neuronal damage associated with traumatic brain injury (TBI) or chronic 
traumatic encephalopathy (CTE). Specific species of microRNAs (miRNA), small, noncoding 
RNA molecules that play gene regulatory functions, are correlated with cellular damage and 
oxidative stress following TBI or CTE, allowing for rapid, minimally-invasive diagnosis and 
assessment of brain injury. The early identification and longitudinal assessment of neuronal 
damage in subjects suffering from or at risk of suffering from a TBI (e.g., football players, 
boxers, military personnel, fall victims) will improve clinical outcomes by guiding critical 
medical and behavioral decision making.
Patent AU-2021274048-A1 (AU)
Title: Spline lubrication for DTH hammers
Inventor: Mäki Jorma
IPC: E21B4/14
Filed: 2021-05-19
Abstract: A down the hole drilling assembly having a top end arranged for coupling to a drill string and bottom cutting end, the drilling assembly comprising: an elongate casing; a fluid powered piston arranged moveably inside the casing which is capable of shuttling axially back and forth having a piston nose positioned at its axially bottom end; a top working chamber at the top end side of the piston and a bottom working chamber at the bottom end side of the piston; a driver sub provided with a set of axially extending driver sub splines on its internal surface; a drill bit having a central bore extending axially therethrough comprising an elongate shank provided with a set of axially extending shank splines on its outer surface for engagement with the driver sub splines to form a spline area; a guide sleeve for forming a first seal with the piston nose wherein the guide sleeve has an inner surface and an outer surface; characterized in that: the guide sleeve forms a second seal with the outer surface of the shank of the drill bit and there is at least one air passageway extending through the guide sleeve and / or the casing for fluidly connecting the bottom chamber to the spline area to provide lubrication thereto.
Patent AU-2021338763-A1 (AU)
Title: Nicotine-free formulations, devices and methods thereof for cessation of smoking or nicotine replacement
Inventor: SHAPIRO DANIEL
IPC: A61M15/06
Filed: 2021-09-09
Abstract: Formulations of nicotine- free compositions, methods of preparing and using same are disclosed. More particularly, the present disclosure relates to methods of preparing inhalable nicotine-free formulations, and to methods for treating a subject with a nicotine-free formulation for use in smoking cessation or nicotine replacement. Also disclosed is a system for controlling cravings and assisting a smoker in quitting smoking or nicotine use.
Patent AU-2021341461-A1 (AU)
Title: Glycoconjugates and medical uses thereof
Inventor: OLIVERA ARDID SARA
IPC: A61P37/00
Filed: 2021-09-08
Abstract: The present invention relates to a polymeric glycoconjugate compound comprising a terminal alpha-galactosyl moiety for use in the treatment of anti-αGal IgE antibodies-mediated diseases. It further relates to new polymeric glycoconjugate compounds, a composition comprising thereof, a method for obtaining thereof and its therapeutic or prophylactic use.
Patent AU-2021341745-A1 (AU)
Title: Electrosurgical device and method of use
Inventor: FREY LAURA
IPC: A61B18/14
Filed: 2021-09-09
Abstract: In an example, an electrosurgical device includes a housing having a proximal end and a distal end, an electrosurgical electrode extending in a distal direction from the distal end of the housing, a plurality of light sources in the housing, and an optical lens assembly including a plurality of optical components that are (i) coupled to each other at a distal end of the optical lens assembly and (ii) separated from each other at a proximal end of the optical lens assembly. Each optical component includes a proximal reflector surface and a distal transmission surface. Each proximal reflector surface extends distally from a respective light source and has an aspheric shape that is configured to substantially collimate the light reflected by the proximal reflector surface. Each distal transmission surface is configured to output the light from the optical component in the distal direction.
Patent AU-2021376330-A1 (AU)
Title: Farming vehicle field boundary identification
Inventor: PELL EDWARD WILLIAM JEFFCOTT
IPC: G01C21/34
Filed: 2021-11-03
Abstract: A system and a method are disclosed for planning a path within a field for a farming machine. The system predicts boundaries of the field using a previously captured image of the field and generates a suggested route to be taken by a data collection device based on the predicted boundaries. As the data collection device travels along the suggested route, the data collection device collects location data associated with a current layout of the field. The location data may be labeled with obstructions encountered along the way. Based on the location data, the system identifies current boundaries of the field, which may be different from the predicted boundaries. The current boundaries are sent to a verification device to be verified. After the current boundaries have been verified, the path for the farming machine is planned.
Patent AU-2021390121-A1 (AU)
Title: Anti-human b7-h3 antibody and application thereof
Inventor: JIAO SHASHA
IPC: C12N15/13
Filed: 2021-12-02
Abstract: Provided are an anti-human B7-H3 monoclonal antibody and an application thereof. By using a recombinant human B7-H3 extracellular region as an immunogen, a murine anti-human B7-H3 monoclonal antibody can be prepared by means of a hybridoma technology, and a murine anti-human B7-H3 antibody can bind to various domains of the B7-H3 extracellular region. A human-mouse chimeric antibody constructed on the basis of a murine antibody can specifically bind to B7-H3 of a cell surface. A humanized antibody prepared by means of CDRs transplantation and CDRs region mutation retains the ability to specifically bind to the human B7-H3 extracellular region and cell membrane surface B7-H3, and can be mediated for internalization by the cell membrane surface B7-H3.
Patent AU-2021395504-A1 (AU)
Title: Modified t cells for adoptive immunotherapy
Inventor: YANG YUAN
IPC: A61K35/17
Filed: 2021-12-01
Abstract: The present invention relates to population of T cells with reduced expression of
Patent AU-2021403948-A1 (AU)
Title: Flotation method and flotation system
Inventor: FUJITA HAYATO
IPC: B03D1/02
Filed: 2021-08-24
Abstract: The purpose of the present invention is to provide a flotation method with which a flotation process can be efficiently performed even when the substance to undergo flotation is fine mineral particles including particles having a particle size of about 25 μm or less.　This is a flotation method that separates and recovers mineral particles through a flotation process, wherein mineral particles are floated in a liquid to be processed by using fine bubbles having a bubble diameter of 200 μm or less and bubbles having a diameter larger than the fine bubbles.
Patent AU-2021405744-A1 (AU)
Title: Compounds comprising a tetrapeptidic moiety
Inventor: CASAZZA ANDREA
IPC: A61K47/64
Filed: 2021-12-22
Abstract: The present invention relates to the field of compounds intended for the treatment of cancer. Selectivity of these compounds is gained through the presence of a specific tetrapeptidic moiety allowing selective release of the drug. The drug in particular is a cytostatic, cytotoxic, or anti-cancer drug. A protective capping group can be introduced to ensure stability of the compound in blood. The tetrapeptidic moieties are ALLP or APKP.
Patent WO-2022204752-A1 (WO)
Title: Production of iron (ii) oxalate
Inventor: WORSLEY JOHN
IPC: C22B3/32
Filed: 2022-03-29
Abstract: Disclosed herein is a method for producing iron (II) oxalate from an insoluble iron material, the method comprising digesting the insoluble iron material with a digestion liquor comprising one or more acids, and reacting digested iron species with a source of oxalate, the oxalate being in stoichiometric excess relative to the digested iron species, to form a slurry comprising iron (II) oxalate and residual oxalate; separating the iron (II) oxalate from the slurry to provide a solids stream comprising the iron (II) oxalate and a liquids stream comprising residual oxalate; and recycling the liquids stream as the source of oxalate or a component thereof.
Patent WO-2023279152-A1 (WO)
Title: Formulation d'aliments émiettés pour ruminants et procédé de préparation de ladite formulation d'aliments émiettés
Inventor: BURGESS BRUCE
IPC: A23K10/33
Filed: 2022-07-05
Abstract: L'invention concerne une formulation d'aliments émiettés destinée à réduire la production de méthane par un ruminant, ladite formulation d'aliments émiettés étant décrite. La formulation d'aliments émiettés comprend une quantité efficace d'au moins une espèce de macro-algues marines rouges combinées à l'intérieur d'un nutriment émietté, ladite formulation d'aliments émiettés présentant une teneur en matière sèche comprise entre environ 85 % et environ 95 % en poids.